RNTX
Price:
$1.39
Market Cap:
$36.54M
Rein Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of a novel class of therapeutics for the treatment of cancer and other diseases. It focuses on its lead product candidate, ALRN-6924, which is a cell-permeating peptide that disrupts the interaction of p53 suppressors MDM2 and MDMX with tumor suppressor p53 to reactivate tumor suppression in non-mutant, or wild-type, p53 cancers. The company was founded by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III, and Loren David Walensky on August 6, 2001 and is headquartered in Austin, TX.
Industry
Medical - Pharmaceuticals
IPO Date
2017-06-29
Stock Exchange
NASDAQ
Ticker
RNTX
According to Rein Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.90. This represents a change of -34.82% compared to the average of 1.38 of the last 4 quarters.
The mean historical Current Ratio of Rein Therapeutics Inc. over the last ten years is 5.26. The current 0.90 Current Ratio has changed 1.61% with respect to the historical average. Over the past ten years (40 quarters), RNTX's Current Ratio was at its highest in in the March 2021 quarter at 20.93. The Current Ratio was at its lowest in in the March 2016 quarter at 0.
Average
5.26
Median
4.14
Minimum
1.58
Maximum
10.69
Discovering the peaks and valleys of Rein Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 227.73%
Maximum Annual Current Ratio = 10.69
Minimum Annual Increase = -61.74%
Minimum Annual Current Ratio = 1.58
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 2.38 | -42.97% |
| 2023 | 4.17 | -35.55% |
| 2022 | 6.46 | -39.52% |
| 2021 | 10.69 | 159.22% |
| 2020 | 4.12 | 23.13% |
| 2019 | 3.35 | -17.43% |
| 2018 | 4.05 | -61.74% |
| 2017 | 10.60 | 104.76% |
| 2016 | 5.18 | 227.73% |
The current Current Ratio of Rein Therapeutics Inc. (RNTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
4.33
5-year avg
5.56
10-year avg
5.26
Rein Therapeutics Inc.’s Current Ratio is greater than Inotiv, Inc. (0.35), greater than HeartBeam, Inc. (0.86), less than 111, Inc. (1.13), less than Tempest Therapeutics, Inc. (2.11), greater than BioAtla, Inc. (0.54), less than Kezar Life Sciences, Inc. (7.29), greater than Celularity Inc. (0.16), less than Actinium Pharmaceuticals, Inc. (7.96), less than Mersana Therapeutics, Inc. (1.39), greater than Quantum BioPharma Ltd. (0.78),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.35 | $30.19M | |
| 0.86 | $24.75M | |
| 1.13 | $32.68M | |
| 2.11 | $15.19M | |
| 0.54 | $49.86M | |
| 7.29 | $45.77M | |
| 0.16 | $47.46M | |
| 7.96 | $45.23M | |
| 1.39 | $137.32M | |
| 0.78 | $38.17M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rein Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Rein Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Rein Therapeutics Inc.'s Current Ratio?
How is the Current Ratio calculated for Rein Therapeutics Inc. (RNTX)?
What is the highest Current Ratio for Rein Therapeutics Inc. (RNTX)?
What is the 3-year average Current Ratio for Rein Therapeutics Inc. (RNTX)?
What is the 5-year average Current Ratio for Rein Therapeutics Inc. (RNTX)?
How does the current Current Ratio for Rein Therapeutics Inc. (RNTX) compare to its historical average?